CVS HEALTH Corp (CVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 40B 80B 120B Q3 '21: 73.8B Q4 '21: 76.6B Q1 '22: 76.8B Q2 '22: 80.6B Q3 '22: 81.2B Q4 '22: 83.8B Q1 '23: 85.3B Q2 '23: 88.9B Q3 '23: 89.8B Q4 '23: 93.8B Q1 '24: 88.4B Q2 '24: 91.2B Q3 '24: 95.4B Q4 '24: 97.7B Q1 '25: 94.6B Q2 '25: 98.9B Q3 '25: 102.9B Q4 '25: 105.7B Q1 '26: 100.4B Q2 '26: 106.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 3B 6B 9B Q4 '13: 6.3B Q1 '14: 5.9B Q2 '14: 6.3B Q3 '14: 6.5B Q4 '14: 6.6B Q1 '15: 6.2B Q2 '15: 6.4B Q3 '15: 6.7B Q4 '15: 7.3B Q1 '16: 6.7B Q2 '16: 7B Q3 '16: 7.5B Q4 '16: 7.6B Q1 '17: 6.6B Q2 '17: 6.9B Q3 '17: 7.1B Q4 '17: 7.9B Q1 '18: 6.9B Q2 '18: 7.2B Q3 '18: 7.3B Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17 Q3 '18

Operating Income Quarterly

-4B -2B 0 2B 4B 6B Q3 '21: 3.1B Q4 '21: 2.3B Q1 '22: 3.5B Q2 '22: 4.7B Q3 '22: -3.9B Q4 '22: 3.7B Q1 '23: 3.4B Q2 '23: 3.2B Q3 '23: 3.7B Q4 '23: 3.4B Q1 '24: 2.3B Q2 '24: 3B Q3 '24: 832M Q4 '24: 2.4B Q1 '25: 3.4B Q2 '25: 2.4B Q3 '25: -3.2B Q4 '25: 2.1B Q1 '26: 4.7B Q2 '26: 4.7B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-4.5B -3B -1.5B 0 1.5B 3B 4.5B Q3 '21: 1.6B Q4 '21: 1.4B Q1 '22: 2.4B Q2 '22: 3B Q3 '22: -3.4B Q4 '22: 2.3B Q1 '23: 2.1B Q2 '23: 1.9B Q3 '23: 2.3B Q4 '23: 2B Q1 '24: 1.1B Q2 '24: 1.8B Q3 '24: 87M Q4 '24: 1.6B Q1 '25: 1.8B Q2 '25: 1B Q3 '25: -4B Q4 '25: 2.9B Q1 '26: 2.9B Q2 '26: 3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 25B 50B 75B Q3 '21: 45B Q4 '21: 46.4B Q1 '22: 45.5B Q2 '22: 49.3B Q3 '22: 50.4B Q4 '22: 51.7B Q1 '23: 51.5B Q2 '23: 53.5B Q3 '23: 54.7B Q4 '23: 57.4B Q1 '24: 48.1B Q2 '24: 50B Q3 '24: 52.9B Q4 '24: 55.3B Q1 '25: 51.1B Q2 '25: 54B Q3 '25: 57B Q4 '25: 59.1B Q1 '26: 55.4B Q2 '26: 58.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-3.5B 0 3.5B 7B 10.5B Q1 '21: 2.9B Q2 '21: 5.8B Q3 '21: 5.5B Q4 '21: 4B Q1 '22: 3.6B Q2 '22: 5.4B Q3 '22: 9.1B Q1 '23: 7.4B Q2 '23: 5.9B Q3 '23: 2.7B Q1 '24: 4.9B Q2 '24: 3.1B Q3 '24: -745M Q4 '24: 1.9B Q1 '25: 4.6B Q2 '25: 1.9B Q3 '25: 796M Q4 '25: 3.4B Q1 '26: 4.2B Q2 '26: 6.3B Q2 '21 Q1 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-3B 0 3B 6B 9B Q1 '21: 2.1B Q2 '21: 5.4B Q3 '21: 4.9B Q4 '21: 3.4B Q1 '22: 2.5B Q2 '22: 5B Q3 '22: 8.5B Q1 '23: 6.5B Q2 '23: 5.3B Q3 '23: 2.2B Q1 '24: 4.2B Q2 '24: 2.5B Q3 '24: -1.4B Q4 '24: 1.1B Q1 '25: 3.8B Q2 '25: 1.3B Q3 '25: 98M Q4 '25: 2.6B Q1 '26: 3.4B Q2 '26: 5.7B Q2 '21 Q1 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q1 '20: 1.3B Q2 '20: 1.3B Q3 '20: 1.3B Q1 '21: 1.3B Q2 '21: 1.3B Q3 '21: 1.3B Q1 '22: 1.3B Q2 '22: 1.3B Q3 '22: 1.3B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q1 '25: 1.3B Q2 '25: 1.3B Q3 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.3B Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q3 '21: 5.72 Q4 '21: 6.02 Q1 '22: 6.11 Q2 '22: 6.30 Q3 '22: 2.51 Q4 '22: 3.26 Q1 '23: 3.14 Q2 '23: 2.33 Q3 '23: 6.67 Q4 '23: 6.47 Q1 '24: 5.70 Q2 '24: 5.63 Q3 '24: 3.95 Q4 '24: 3.67 Q1 '25: 4.20 Q2 '25: 3.59 Q3 '25: 0.39 Q4 '25: 1.39 Q1 '26: 2.28 Q2 '26: 3.79 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.